Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Singapore-based Celligenics operates in Biotechnology Research. Privately held, at celligenics.com. It holds one address on record, all in Singapore. It employs 7 people, on the record. It lists biotechnology among its specialties. One Singapore registration (UEN) is a confirmed match. Its latest round on record is Series A, US$4.2M. It is listed alongside nine similar brands, mostly in Biotechnology Research.
UEN201623485E
| CELLIGENICS PTE. LTD. | UEN 201623485E |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Celligenics is a biotechnology company specialised in the development of future-relevant solutions through stem cell technology in a new era of regenerative medicine.
Celligenics aims to be a global leader in the innovative isolation and application of human stem cells and its derivatives, and to empower humanity with unprecedented regenerative healthcare solutions that will enhance the quality of human life.
Celligenics possesses strong credentials in the dual-facet of enterprise development and scientific research. The collective team has core expertise in enterprise strategy, investment finance, research & development, as well as experience in the field of working with molecular and cell biology.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
| Rounds | 1 |
|---|---|
| Axis | 2016 to 2026 |
| Series A · 14 Feb 2019 | US$ 4.2M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One Singapore entity on ACRA: CELLIGENICS PTE. LTD. (UEN 201623485E), high confidence.
7 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
One address on record, Singapore only. Primary: 10 Biopolis Rd, #05-01/06, Chromos, Singapore 138671.
One round. Latest 14 February 2019: Series A, US$4,200,000, investor Best World International.
One tag on the brand's own list, among them biotechnology.
10 profiles list Celligenics as a peer — 82nd percentile in Biotechnology Research. It lists ten peers of its own. SG Austria and Austrianova list it back.